ABSTRACT DNA transfection analyses (tumorigenicity assay) and hybridization to mutation specific oligonucleotide probes established point mutations in codon 61 of both, N-ras and Ki-ras genes in fresh leukemic cells of an AML patient. Concurrent activation of N-ras and Ki-ras sequences by point mutations in codons 12 were demonstrated for AML cell line Rc2a. Moreover, using a rapid and sensitive dot-blot screening procedure based on the combination of in vitro amplification of ras specific sequences and oligonucleotide hybridization we could show that ras gene activation was not present in primary leukemic cells of the patient this cell line had been derived from, but rather occurred during later passages of Rc2a.
INTRODUCTION
The activation of ras genes by point mutation is one of the best studied mechanisms that convert proto-oncogenes to transforming sequences (1) . The human ras gene family comprises the active members, Ha-ras, Ki-ras, and N-ras.
Each gene encodes a 21 KB protein closely related to the others (2) . While the precise physiological function(s) of p21 ras remain(s) to be elucidated, some of their biochemical and biological characteristics suggest that these proteins, by analogy with G-like proteins, are involved in transduction of receptor-mediated external signals into cells. Thus p21 ras proteins bind guanine nucleotides, exhibit intrinsic GTPase activity and are localized at the inner surface of the plasma membrane (3) (4) (5) .
Cloning and sequence analyses of oncogenic versions of ras genes have demonstrated point mutations in codons 12, 13 or 61 of Ha-, Ki-, or N-ras resulting in substitution of amino acids in respective p21 proteins (1, 6) . These molecular alterations are associated with a decrease in GTPase activity (7, 8) . Yet the biological meaning of the latter modification is not settled thus far (9, 10) .
Data suggesting that a cooperation of different oncogenes is essential for the manifestation of a transformed cellular phenotype fit well in the gene-rally accepted view of carcinogenesis as a multistep process (2) . Indeed such a cooperation has been established e.g. for ras and myc sequences both in vitro and in vivo (2, (11) (12) (13) . However, not only mutated versions of p21, but also overexpression of normal ras sequences, result in cellular transformation (14) (15) (16) . A combination of both modes of activation, i.e. point mutation and overexpression via gene amplification, has recently been demonstrated for the two Ki-ras alleles in a human gastric carcinoma (17) . Herein we report for the first time a concurrent activation of two different ras genes (Ki-and N-ras) by point mutations in an AML cell line (Rc2a) as well as in fresh leukemic cells of an additional AML patient.
MATERIALS AND METHODS

Cell Samples
Different passages of cell line Rc2a as well as primary leukemic cells of the AML patient this line has been derived from (18) were generously provided by Dr. T.R. Bradley. These samples comprised 1) peripheral blood cells from the first presentation of the patient R.C. (frozen October 76), 2) peripheral blood cells taken just prior to patient's death, grown for A weeks with colony stimulating factor (CSF) as described (18) and then frozen (prior to chemotherapy) were purified over Ficoll gradients and used for further analyses.
Transfection Assay. High-molecular weight DNA was prepared according to standard methods. DNA transfer used a modified calcium phosphate precipitation method with NIH 3T3 cells as recipients as described in detail elsewhere (19) . The tumorigenicity assay is based on the cotransfection of 3T3 fibroblasts with tumor DNA and a dominant drug-resistant selectable marker, pRSVneo, followed by G418 (600 Mg/ml, GIBCO Laboratories) selection and injection of resulting 3T3 colonies into nude mice. NIH 3T3 fibroblasts were originally obtained from M. Wigler and subcloned by us as described previously (19) . Transfection of 20 ug leukemic DNA with 500 ng of pRSVneo (20) Southern Blot Analyses. Cellular DNAs were digested with restriction endonucleases (Boehringer Mannheim), electrophoresed on a 0.7% agarose gel, blotted and hybridized as described (19) . Moreover, 2 ug/ml pRSVneo DNA was added as competitor DNA to avoid cross hybridization with cotransfected pRSVneo sequences.
Inserts of the following ras probes were used: pEJ (hu-Ha-ras; 22), p640
(hu-Ki-ras; 23) and 0.9 kb PvuII fragment B (hu-N-ras; 24).
Synthetic OliRonucleotide Probes. The oligonucleotides (20-mers) were prepared by one of us (J.L.) via an asynchronous simultaneous synthesis strategy (25) using the solid-phase phosphite triester method. For Table I we selected those 20-mers that proved to be informative for the present study. A complete list of oligomers used for our analyses of ras gene mutations is avail-32 able on request. The oligomers were end-labelled using -P-ATP (New England Nuclear, Boston, MA) and T,-polynucleotide kinase (Pharmacia). The kinased probes were separated from the unincorporated ATP by chromatography on Sephadex G 50 in TEN (100 mM NaCl, lOmM Tris-HCl, pH 7.5, 1 mM EDTA).
Specific activities were greater than 2 x 10 cpm/pmol. Oligomer Hybridization. DNA was digested with Pst I or EcoRI (Boehringer Mannheim, FRG) to detect mutations in the N-ras and Ki-ras genes, respectively, and fractionated by electrophoresis in 0.6% agarose. The gel was treated as described (26) with an outer set of amplimers followed by 15 rounds of amplification using an inner set of amplimers (28) . Dot Blot Hybridization. 1 pi of the DNA amplified in vitro was spotted onto Nylon filters (Gene Screen Plus, New England Nuclear, Boston, MA). The filters were subsequently illuminated with a 254-nm UV lamp (1.6 kJ/m ) to bind the DNA to the filter. The filters were prehybridized over night at 50°C in 5 x SSPE, 7% SDS, 100 ug/ml sonicated, denaturated salmon sperm DNA, and 5 x Denhardt's solution and subsequently hybridized for 3 h at 50°C in the same mixture containing approximately 1 ng P-labelled oligomer probe. The filters were washed twice in 2 x SSPE, 0.1% SDS for 5 min at room temperature, followed by a 30 min wash at 50°C in 5 x SSPE, 0.1% SDS. Subse- quently, the filters were stringently washed in 5 x SSPE, 0.1% SDS for 10 min. Finally, the filters were exposed up to 12 hrs to Kodak XAR films at -70°C using intensifying screens.
RESULTS
DNA transfection analyses
In a series of transfection analyses using the tumorigenicity assay we obser- Southern blot analysis demonstrated the presence of human N-ras sequences in both M.P. transfectants (Fig. 1A) . However, rehybridization of respective filters to a human Ki-ras probe showed likewise a strong positive autoradiographic band for MP-T_ DNA as well as a faint hybridization signal for MP-T.
( and T, (weak signal), but not in Rc2a-T., and T o DNAs (Fig. 3A) . Moreover, While in patient M.P. the ras gene activations may be related to leukemogenesis, this possibility is ruled out for patient R.C. from whom cell line Rc2a has been derived. In the latter case cell passages prior to and after acquisition of mutated ras versions did not differ with respect to a variety of morphological, phenotypic, biochemical or cytogenetic parameters tested (18) . However, in view of the molecular changes reported here different passages of Rc2a may offer a unique opportunity to study the meaning of mutated ras genes for the human myeloid lineage in much more detail.
